Even so, some experts found that it can be difficult to apply AI to treating complex medical conditions. Having access to data that represents patient populations broadly has been a challenge, experts told the Journal, and gaps in knowledge about complex diseases may not be fully captured in clinical databases. "I believe that we're many years away from AI products that really positively impact clinical care for many patients," said Bob Kocher, a partner at venture-capital firm Venrock who focuses on healthcare IT and services investments and who was a White House health adviser under President Barack Obama. Software that makes recommendations on personal medical treatments needs data on what actions have worked in the past. But data on medical histories and treatment outcomes aren't always complete, may be recorded in different formats, and may be sitting in various systems owned by insurance carriers, health providers and other organizations.

But, 58% of businesses say that less than 10% of their company's digital budget goes towards AI. So, it's not surprising that only 15% of AI projects succeed. This disconnect comes as no surprise to us. I was an analyst at Morgan Stanley and earned my technology stripes (and scars) at Apple under Steve Jobs, while my partner and wife, Helen, is a former CIO and corporate venture capitalist. We know the hallmarks of innovation window-dressing and transformation-by-outsourcing.

Electric scooters are invading America, with scooters from popular brands including Lime, Bird, Spin, Lyft, and Uber becoming commonplace in major city centers. These dockless scooters, which are controlled by mobile app, accounted for 45.8% of all micromobility trips in 2018; this number is significant, considering 84 million micromobility trips were taken in 2018 alone, the National Association of City Transportation Officials reported. The success of scooters are built on the promises of reducing traffic congestion, providing a more efficient and cost-effective means of travel, and decreasing harmful emissions, according to the INRIX's Micromobility Potential in the US, UK and Germany report. However, scooters are also responsible for at least 1,500 injuries and eight fatalities of US riders since late 2017. The injuries and deaths have caused many US cities to take pause, with Atlanta recently banning scooter usage during nighttime hours, and San Diego considering a temporary ban.

The month-long launch window for NASA's new Mars lander, InSight opens this weekend. InSight will be the first spacecraft to use a robotic arm to place its instruments on another planet's soil--effectively unraveling the innards of the Red Planet. It's also the first interplanetary mission to launch from the West Coast instead of Cape Canaveral, and it may not be the last. Its mission is to peer deep into Mars with two main instruments. One is a probe that'll hammer 16 feet deep to take the planet's temperature and determine how much heat it's losing.

Of the many great things promised by Crispr gene editing technology, the ability to eliminate disease by modifying organisms might just top the list. But doing that requires perfecting something called a gene drive. Think of gene drives as a means of supercharging evolution to, say, give an entire population of mosquitoes a gene that kills the Zika virus. The trouble is, organisms develop resistance to gene drives, much like they eventually outwit pesticides and antibiotics. Researchers dedicate no small amount of time and thought to creating gene drives that can outsmart evolution because the potential payoffs are so great.